680 results on '"Najimi, Mustapha"'
Search Results
2. Expansion of human allogeneic liver-derived progenitor cells for liver regenerative therapy in serum-free culture conditions
3. Zell- und stammzellbasierte Therapien für Leberdefekte: Aktuelle Fortschritte und zukünftige Strategien
4. The immunogenic profile and immunomodulatory function of mesenchymal stromal / stem cells in the presence of Ptychotis verticillata
5. Fibrotic liver extracellular matrix induces cancerous phenotype in biomimetic micro-tissues of hepatocellular carcinoma model
6. A Shadow of Knowledge in Stem Cell Science
7. Amino Acids Transport as an Index of Cancer Stem Cells Dysregulation
8. Skeletal Muscle–Extricated Extracellular Vesicles: Facilitators of Repair and Regeneration : Facilitators of Repair and Regeneration
9. Extracellular Vesicles Derived from Mesenchymal Stem Cells : Biological Activity and Approaches of Large-Scale Production
10. Current Trends and Future Outlooks of Dental Stem-Cell-Derived Secretome/Conditioned Medium in Regenerative Medicine
11. Regenerative Medicine Applied to the Treatment of Musculoskeletal Pathologies : The Cell-Free Therapy Approach
12. Exosome-Based Cell-Free Therapy in Regenerative Medicine for Myocardial Repair
13. Mesenchymal Stem Cell-Extracellular Vesicle Therapy in Patients with Stroke
14. Mesenchymal Stem Cell Secretome: A Potential Biopharmaceutical Component to Regenerative Medicine
15. Extracellular Vesicles-Based Cell-Free Therapy for Liver Regeneration
16. Deciphering the possible reciprocal loop between hepatic stellate cells and cancer cells in the tumor microenvironment of the liver
17. SAT-537 Characterization of immune cell populations in the microenvironment of mice liver during the progression of liver fibrosis to hepatocellular carcinoma
18. THU-092 Enrolling patients in ACLF trials-the need to increase ACLF awareness (DHELIVER trial)
19. Bioscreening and pre-clinical evaluation of the impact of bioactive molecules from Ptychotis verticillata on the multilineage potential of mesenchymal stromal cells towards immune- and inflammation-mediated diseases
20. Mesenchymal Stem Cells and Tissue Bioengineering Applications in Sheep as Ideal Model.
21. Wharton's Jelly mesenchymal stem cell‐derived extracellular vesicles induce liver fibrosis‐resolving phenotype in alternatively activated macrophages.
22. Cell- and Stem Cell-Based Therapies for Liver Defects: Recent Advances and Future Strategies
23. A phase II study of human allogeneic liver-derived progenitor cell therapy for acute-on-chronic liver failure and acute decompensation
24. Single-cell RNA sequencing of human liver reveals hepatic stellate cell heterogeneity
25. Immune regulation and therapeutic application of T regulatory cells in liver diseases
26. Longitudinal study of Pex1-G844D NMRI mouse model: A robust pre-clinical model for mild Zellweger spectrum disorder
27. Immuno-comparative screening of adult-derived human liver stem/progenitor cells for immune-inflammatory-associated molecules
28. Accurate and live peroxisome biogenesis evaluation achieved by lentiviral expression of a green fluorescent protein fused to a peroxisome targeting signal 1
29. Circulating Tumor Cells as a Promising Tool for Early Detection of Hepatocellular Carcinoma
30. Quiescent hepatic stellate cell activation in liver fibrosis: Have we found the right trigger yet?
31. Hepatic fibrosis: It is time to go with hepatic stellate cell-specific therapeutic targets
32. Immuno-biological comparison of hepatic stellate cells in a reverted and activated state
33. Evidence for an alternative fatty acid desaturation pathway increasing cancer plasticity
34. Amniotic Membrane and Its Derivatives: Novel Therapeutic Modalities in Liver Disorders
35. (‐)‐Epigallocatechin‐3‐gallate induced apoptosis by dissociation of c‐FLIP/Ku70 complex in gastric cancer cells
36. Conditioned medium from human allogeneic liver-derived progenitor cells protects against LPS-induced endothelial hyperpermeability via shingosine-1 phosphate
37. Safety, tolerability, and preliminary efficacy of ascending doses of Human Allogeneic Liver-derived Progenitor Cells (HepaStem®) in patients with cirrhotic and pre-cirrhotic non-alcoholic steatohepatitis (NASH)
38. ACLF course profiles over screening period in the phase IIb DHELIVER study
39. Characterization of the cystine/glutamate antiporter in cultured Bergmann glia cells
40. Silibinin induces hepatic stellate cell cycle arrest via enhancing p53/p27 and inhibiting Akt downstream signaling protein expression
41. Amino acid levels determine metabolism and CYP450 function of hepatocytes and hepatoma cell lines
42. Senescence and senotherapies in biliary atresia and biliary cirrhosis
43. Premature senescence of the liver in Alagille patients
44. The global downregulation of protein synthesis observed during hepatogenic maturation is associated with a decrease in TOP mRNA translation
45. CHARACTERISATION OF KUPFFER CELL AND INFILTRATING MONO-MACROPHAGE POPULATIONS IN CCl4 INDUCED LIVER DAMAGE model
46. The global downregulation of protein synthesis observed during hepatogenic maturation is associated with a decrease in TOP mRNA translation
47. Coupling of glutamate and glucose uptake in cultured Bergmann glial cells
48. Novel human hepatic organoid model enables testing of drug-induced liver fibrosis in vitro
49. Liver Engraftment and Repopulation by In Vitro Expanded Adult Derived Human Liver Stem Cells in a Child with Ornithine Carbamoyltransferase Deficiency
50. Phase I/II Trial of Liver–derived Mesenchymal Stem Cells in Pediatric Liver–based Metabolic Disorders: A Prospective, Open Label, Multicenter, Partially Randomized, Safety Study of One Cycle of Heterologous Human Adult Liver–derived Progenitor Cells (HepaStem) in Urea Cycle Disorders and Crigler-Najjar Syndrome Patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.